About Indraprastha Medical Corporation Limited

Indraprastha Medical Corporation Limited (IMCL), popularly known as Indraprastha Apollo Hospitals, is a public company incorporated in India with its registered office and principal hospital complex at Sarita Vihar, Delhi–Mathura Road, New Delhi – 110 076. The company is primarily engaged in providing comprehensive, high-quality hospital services on a cost-effective basis and is listed on BSE and NSE. It operates multi-specialty hospitals in New Delhi and Noida, delivering international-standard medical care across a wide range of specialties under one roof.

IMCL’s services span inpatient and outpatient care, including examinations, treatments, surgeries, investigations, accommodation, nursing, and the supply of consumables. Revenue is recognised when each performance obligation is satisfied, reflecting the breadth of hospital services from room charges to specialised clinical procedures. The hospital is accredited by the Joint Commission International (JCI), USA, underscoring its adherence to global standards in patient care and hospital management.

The company’s two hospital locations are Indraprastha Apollo Hospitals, Sarita Vihar, Delhi–Mathura Road, New Delhi – 110076 and Apollo Hospitals, E-2, Sector – 26, Noida – 201 301.

IMCL serves a growing international patient base. It has been empanelled with eminent international insurance companies and appointed as a healthcare facilitator in various countries to cater to international patients. During the year, foreign exchange earnings were Rs 243.42 crore, with an outgo of Rs 53.34 crore, reflecting the company’s cross-border healthcare services footprint.

Operationally, the latest year saw 64,423 discharges and 596,285 out-patient visits, with an average length of stay of 3.07 days. Discharges and out-patient volumes each grew 7% year-on-year, highlighting continued demand for IMCL’s services. The company reported 3,035 permanent employees on its rolls as on March 31, 2025, supported by additional contracted workforce for hospital support services.

Number of subsidiaries: 0. The company has no subsidiary, associate or joint venture, and is not required to prepare consolidated financial statements.

Key Milestones of Indraprastha Medical Corporation Limited

Key milestones achieved include sustained JCI accreditation and the hospital’s recognition for excellence in complex, high-risk procedures across specialties such as transplants, cardiology, oncology, neurology, and orthopaedics.

Indraprastha Medical Corporation Limited Business Verticals and Geographical Presence

IMCL operates multi-specialty hospitals providing comprehensive inpatient and outpatient care, including examinations, treatments, surgeries, investigations, accommodation, nursing, and supply of consumables. Key specialties include transplants, cardiology, oncology, neurology, and orthopaedics. The company operates in New Delhi (Sarita Vihar, Delhi–Mathura Road) and Noida (E-2, Sector–26). The hospital serves both domestic and international patients, with foreign exchange earnings of Rs 243.42 crore in the latest year.

Indraprastha Medical Corporation Limited Key Management

• Dr. Prathap C. Reddy – Vice Chairman
• Shivakumar Pattabhiraman – Managing Director
• C. P. Tyagi – Chief Financial Officer
• Priya Ranjan – Company Secretary

Latest Updates on Indraprastha Medical Corporation Limited

• Industry recognition: Indraprastha Apollo Hospitals was named the Best Private Multispecialty Hospital in Delhi (The Week – Hansa Research survey), featured among the World’s Best Hospitals (Newsweek), and received Excellence in clinical services (AHPI) and a national sustainability award (CAHOCON). It also received recognition at the Sanjeevani 2024 healthcare and wellness expo in paediatric haematology & bone marrow transplant, kidney transplant, and radiation oncology.
• Strategic focus: The company is expanding its Centres of Excellence, increasing the share of advanced procedures and innovative therapies, enhancing insurance payer mix, and driving cost-optimisation and efficiency measures to strengthen margins and ROCE.
• Clinical excellence: IMCL continues to benchmark outcomes against global standards, maintaining strong performance in complex specialties while investing in training and continuing medical education for clinicians and staff.
• International patient services: The hospital deepened its international facilitation through empanelment with overseas insurers; foreign exchange earnings stood at Rs 243.42 crore during the year, highlighting the scale of international patient flows.
• Credit ratings: ICRA reaffirmed long-term fund-based cash credit at [ICRA]AA and short-term non-fund based at [ICRA]A1+, and assigned [ICRA]AA to Rs 100.00 crore of term loan facilities.
• Operating indicators: Discharges and out-patients grew 7% year-on-year; revenue per bed day improved by 5% during the year ended March 31, 2025, reflecting continued operational momentum.